This brand name is authorized in Nigeria.
The drug GENTABETA contains one active pharmaceutical ingredient (API):
1
|
UNII
8X7386QRLV - GENTAMICIN SULFATE
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-4094 | Injection | GENTABETA INJECTION INJ 80 mg/2 mL 2mlx10Ampoules | 61 RNW-PP-313300 GENTABETA INJECTION GENTAMYCIN INJECTION 80MG/2ML Gentamicin sulfate 80mg/2ml Sodium metabisulfite EDTA-2Na Anhydrous sodium carbonate Water for Injection B4-4094 Drugs Imported Products 2mlx10Ampoules Prescription Only Medicine (POM) 2/9/2023 LABETA DRUGS LIMITED, NO 125C OLAITAN STREET, OFF NNOBI STREET, SURULERE LAGOS 18544878 greenabeta_nig@yahoo.com ANHUI CHENGSHI PHARMACEUTICAL CO,. LTD, NO. 5068 HUAISHANG ROAD, BENGBU, ANHUI PROVINCE . CHINA, China | 31/01/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
J01GB03 | Gentamicin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-4094 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.